Livanova Plc Stock Performance
| LIVN Stock | USD 36.78 0.01 0.03% |
The company secures a Beta (Market Risk) of -0.15, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning LivaNova PLC are expected to decrease at a much lower rate. During the bear market, LivaNova PLC is likely to outperform the market. At this point, LivaNova PLC has a negative expected return of -0.37%. Please make sure to verify LivaNova PLC's value at risk, daily balance of power, as well as the relationship between the Daily Balance Of Power and price action indicator , to decide if LivaNova PLC performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days LivaNova PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in June 2025. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
| Begin Period Cash Flow | 577.9 M |
LivaNova PLC Relative Risk vs. Return Landscape
If you would invest 4,806 in LivaNova PLC on February 3, 2025 and sell it today you would lose (1,128) from holding LivaNova PLC or give up 23.47% of portfolio value over 90 days. LivaNova PLC is currently does not generate positive expected returns and assumes 3.0255% risk (volatility on return distribution) over the 90 days horizon. In different words, 27% of stocks are less volatile than LivaNova, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
LivaNova PLC Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for LivaNova PLC's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as LivaNova PLC, and traders can use it to determine the average amount a LivaNova PLC's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1223
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | LIVN |
Estimated Market Risk
| 3.03 actual daily | 27 73% of assets are more volatile |
Expected Return
| -0.37 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average LivaNova PLC is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of LivaNova PLC by adding LivaNova PLC to a well-diversified portfolio.
LivaNova PLC Fundamentals Growth
LivaNova Stock prices reflect investors' perceptions of the future prospects and financial health of LivaNova PLC, and LivaNova PLC fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on LivaNova Stock performance.
| Return On Equity | 0.0487 | ||||
| Return On Asset | 0.0419 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 2.25 B | ||||
| Shares Outstanding | 54.52 M | ||||
| Price To Earning | 78.67 X | ||||
| Price To Book | 1.52 X | ||||
| Price To Sales | 1.60 X | ||||
| Revenue | 1.25 B | ||||
| EBITDA | 202.52 M | ||||
| Cash And Equivalents | 109.02 M | ||||
| Cash Per Share | 2.04 X | ||||
| Total Debt | 676.77 M | ||||
| Debt To Equity | 0.40 % | ||||
| Book Value Per Share | 24.29 X | ||||
| Cash Flow From Operations | 183.04 M | ||||
| Earnings Per Share | 1.16 X | ||||
| Total Asset | 2.51 B | ||||
| Retained Earnings | (903.25 M) | ||||
| Current Asset | 240.72 M | ||||
| Current Liabilities | 31.45 M | ||||
About LivaNova PLC Performance
By examining LivaNova PLC's fundamental ratios, stakeholders can obtain critical insights into LivaNova PLC's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that LivaNova PLC is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom. Livanova Plc operates under Medical Equipment classification in the United States and is traded on NASDAQ Exchange. It employs 3000 people.Things to note about LivaNova PLC performance evaluation
Checking the ongoing alerts about LivaNova PLC for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for LivaNova PLC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| LivaNova PLC generated a negative expected return over the last 90 days | |
| LivaNova PLC has high historical volatility and very poor performance | |
| Over 100.0% of the company shares are owned by institutional investors |
- Analyzing LivaNova PLC's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether LivaNova PLC's stock is overvalued or undervalued compared to its peers.
- Examining LivaNova PLC's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating LivaNova PLC's management team can have a significant impact on its success or failure. Reviewing the track record and experience of LivaNova PLC's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of LivaNova PLC's stock. These opinions can provide insight into LivaNova PLC's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LivaNova PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. To learn how to invest in LivaNova Stock, please use our How to Invest in LivaNova PLC guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Medical Equipment space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LivaNova PLC. If investors know LivaNova will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LivaNova PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of LivaNova PLC is measured differently than its book value, which is the value of LivaNova that is recorded on the company's balance sheet. Investors also form their own opinion of LivaNova PLC's value that differs from its market value or its book value, called intrinsic value, which is LivaNova PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LivaNova PLC's market value can be influenced by many factors that don't directly affect LivaNova PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LivaNova PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if LivaNova PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LivaNova PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.